CBP suspends all personal prescription importation Oct 22

The suspension of personal prescription importation by U.S. Customs and Border Protection could significantly impact Americans who rely on affordable Canadian pharmacies for medications, potentially increasing their healthcare costs. This policy shift raises broader concerns about drug pricing and access to affordable healthcare in the U.S.

• CBP has suspended personal prescription drug importation starting October 22.
• Americans previously relied on Canadian pharmacies for cheaper medications with a strong safety record.
• This move may increase pressure on U.S. drug pricing debates and consumer advocacy efforts.